Government recognises ‘very significant work’ by industry on Brexit planning

The Government has recognised the industry for “very significant work” in planning for Brexit.

At the Oireachtas Committee on Health on Wednesday, the Secretary General of the Department of Health, Jim Breslin, outlined the steps the health authorities, working with industry and other stakeholders, are taking to secure the supply of medicines to patients after Brexit.

Read more

European lawmakers on course to weaken IP incentives environment

Lawmakers in Brussels are on track towards weakening the environment for the discovery and adoption of medical innovation, potentially putting at risk the development of new treatments and high-quality jobs at the frontiers of research.

Read more

Brexit demands us all to work together for patients

There’s a saying in Brussels called going ‘into the tunnel’. It’s when negotiators get together to try to plot a path to resolving Brexit. As the political turmoil continues, one certainty is that pharmaceutical innovators have been meticulously planning for Brexit. For two years or more, they have been reorganising supply chains and revising regulatory approvals. This work is critical in minimising the risk of disruption to the supply of medicines to patients after March 29th.

Read more

Two-Thirds of People Say Patients’ Wait For New Medicines is ‘Unacceptable’ - Ipsos MRBI

Two-thirds of people feel it is ‘unacceptable’ that life-changing medicines are available to patients in other countries before our own can get them, according to a survey conducted by Ipsos MRBI on behalf of Irish Pharmaceutical Healthcare Association (IPHA), the organisation that represents pharmaceutical innovators in Ireland.

Read more

The pharma year unwrapped

As we near the end of the year, it’s a good time to look back on just some of the highlights of our public communications and advocacy.

Read more

IPHA uses roundtable to outline industry’s Brexit preparations

With less than four months to Brexit Day, 29th March 2019, the pharmaceutical industry continues to require clarity and advice on its impact on Ireland, both from a practical and political perspective. 

Read more

Vice Chancellor of Oueen's University Belfast outlines new vision for life sciences

Professor Ian Greer, the new Vice Chancellor of Queen’s University Belfast gave an inspirational Annual Lecture of the Association of the British Pharmaceutical Industry at Stormont Buildings on 20th November.

Read more